TWITTER – DIGNICAP

A breast cancer vaccine can now be tested in human trials after its investigational new drug application was accepted by the U.S. Food and Drug Administration (FDA).

https://buff.ly/35GEHMK

Roche has announced the CE-IVD launch of its automated digital pathology algorithms for #breastcancer to help to select the best treatment approach for each patient.

https://buff.ly/2XAwmWb

"Being able to keep my hair, look in the mirror, not have to buy a wig and not look so sick made all the difference... It was just so worth it." - Therese

@nyphospital @WeillCornell

#DigniCap #scalpcooling #coldcaps #hairloss #chemotherapy https://buff.ly/35Cc6b4

. @AmericanCancer announces record drop in #CancerMortality for second straight year. #CancerStatistics

Article: https://bit.ly/2XAOAHo
Release: https://bit.ly/35wPKrA

Load More...

FACEBOOK – DIGNICAP

4 days ago

DigniCap

"Being able to keep my hair, look in the mirror, not have to buy a wig and not look so sick made all the difference... It was just so worth it." - Therese

NewYork-Presbyterian Hospital
...

View on Facebook
Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

OPERATIONS
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 877-350-2150

HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

HEADQUARTERS
Dignitana S.r.l.
Corso di Porta Nuova, 46
20121 Milan, Italy